Business Description
Feng Chi Biotech Corp
ISIN : TW0006744006
Share Class Description:
ROCO:6744: Ordinary SharesTotal Employee Number:
37Description
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 32.91 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.19 | |||||
Interest Coverage | 76.5 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.75 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3 | |||||
3-Year EBITDA Growth Rate | -7.5 | |||||
3-Year EPS without NRI Growth Rate | -16.2 | |||||
3-Year Book Growth Rate | 0.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.3 | |||||
9-Day RSI | 63.33 | |||||
14-Day RSI | 56.08 | |||||
3-1 Month Momentum % | 9.66 | |||||
6-1 Month Momentum % | -10.67 | |||||
12-1 Month Momentum % | -20.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.14 | |||||
Quick Ratio | 4.38 | |||||
Cash Ratio | 3.95 | |||||
Days Inventory | 105.54 | |||||
Days Sales Outstanding | 28.37 | |||||
Days Payable | 58.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.13 | |||||
Dividend Payout Ratio | 1.01 | |||||
3-Year Dividend Growth Rate | -8.7 | |||||
Forward Dividend Yield % | 5.42 | |||||
5-Year Yield-on-Cost % | 6.15 | |||||
Shareholder Yield % | 7.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.63 | |||||
Operating Margin % | 7.81 | |||||
Net Margin % | 8.16 | |||||
EBITDA Margin % | 16.49 | |||||
FCF Margin % | -5.58 | |||||
OCF Margin % | 1.82 | |||||
ROE % | 6.09 | |||||
ROA % | 4.87 | |||||
ROIC % | 14.49 | |||||
3-Year ROIIC % | -43.9 | |||||
ROC (Joel Greenblatt) % | 46.61 | |||||
ROCE % | 7.08 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.81 | |||||
PE Ratio without NRI | 16.81 | |||||
Shiller PE Ratio | 9.96 | |||||
PS Ratio | 1.38 | |||||
PB Ratio | 1.01 | |||||
Price-to-Tangible-Book | 1.01 | |||||
Price-to-Operating-Cash-Flow | 75.24 | |||||
EV-to-EBIT | 4.1 | |||||
EV-to-EBITDA | 2.4 | |||||
EV-to-Revenue | 0.4 | |||||
EV-to-FCF | -6.78 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 0.66 | |||||
Price-to-Graham-Number | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 1.32 | |||||
| Price-to-Net-Cash | 1.86 | |||||
Earnings Yield (Greenblatt) % | 24.39 | |||||
FCF Yield % | -4.07 | |||||
Forward Rate of Return (Yacktman) % | 1.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Feng Chi Biotech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 177.36 | ||
| EPS (TTM) (NT$) | 0.94 | ||
| Beta | 0.0594 | ||
| 3-Year Sharpe Ratio | -1.17 | ||
| 3-Year Sortino Ratio | -1.42 | ||
| Volatility % | 21.52 | ||
| 14-Day RSI | 56.08 | ||
| 14-Day ATR (NT$) | 0.361568 | ||
| 20-Day SMA (NT$) | 15.24 | ||
| 12-1 Month Momentum % | -20.1 | ||
| 52-Week Range (NT$) | 13.3 - 22.1 | ||
| Shares Outstanding (Mil) | 15.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Feng Chi Biotech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Feng Chi Biotech Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.840000 Cash Dividend | 2026-07-21 | In 7 days | ||
| TWD 0.950000 Cash Dividend | 2025-07-22 | 20.50 (+3.02%) | ||
| TWD 1.050000 Cash Dividend | 2024-07-22 | 22.45 (-0.88%) |
Show
Entries
Feng Chi Biotech Corp Frequently Asked Questions
What is Feng Chi Biotech Corp(ROCO:6744)'s stock price today?
The current price of ROCO:6744 is NT$15.80. The 52 week high of ROCO:6744 is NT$22.10 and 52 week low is NT$13.30.
When is next earnings date of Feng Chi Biotech Corp(ROCO:6744)?
The next earnings date of Feng Chi Biotech Corp(ROCO:6744) is .
Does Feng Chi Biotech Corp(ROCO:6744) pay dividends? If so, how much?
The Dividend Yield %  of Feng Chi Biotech Corp(ROCO:6744) is 6.13% (As of Today), Highest Dividend Payout Ratio of Feng Chi Biotech Corp(ROCO:6744) was 1.01. The lowest was 0.55. And the median was 0.85. The  Forward Dividend Yield % of Feng Chi Biotech Corp(ROCO:6744) is 5.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Feng Chi Biotech Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers